-+ 0.00%
-+ 0.00%
-+ 0.00%

China Biotechnology Services: The Group entered into a master cooperation agreement with Stella Pharma to jointly promote the development and commercialization of Steboronine® in China. This cooperation forms a synergy with the Group's flagship project at Pengbo Hainan Boron Neutron Hospital and marks an important strategic initiative of the Group to introduce advanced boron neutron therapy technology into the Chinese market to further consolidate and develop its business in China.

Zhitongcaijing·08/12/2026 00:33:05
Listen to the news
China Biotechnology Services: The Group entered into a master cooperation agreement with Stella Pharma to jointly promote the development and commercialization of Steboronine® in China. This cooperation forms a synergy with the Group's flagship project at Pengbo Hainan Boron Neutron Hospital and marks an important strategic initiative of the Group to introduce advanced boron neutron therapy technology into the Chinese market to further consolidate and develop its business in China.